SEC Form 4 · accession 0000899243-15-002778
Aimmune Therapeutics, Inc. · AIMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Aug 11, 2015
Accepted (ET)
Aug 11, 2015 · 11:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631650
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par valueF1,F2 | Aug 11, 2015 | C | 3,873,530 | — | A | 3,873,530 | I | By: Longitude Venture Partners II, L.P. |
| Common Stock, $0.0001 par valueF1,F2 | Aug 11, 2015 | C | 3,248,600 | — | A | 7,122,130 | I | By: Longitude Venture Partners II, L.P. |
| Common Stock, $0.0001 par valueF2 | Aug 11, 2015 | P | 312,500 | $16.00 | A | 7,434,630 | I | By: Longitude Venture Partners II, L.P. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1,F2,F4 | — | Aug 11, 2015 | C | 3,873,530 | D | — | — | Common Stock | 3,873,530 | 0 | I |
| Series B Convertible Preferred StockF1,F2,F4 | — | Aug 11, 2015 | C | 3,248,600 | D | — | — | Common Stock | 3,248,600 | 0 | I |
Explanation of responses
- F1The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Issuer's Common Stock on a 1 for 1 basis immediately prior to the closing of Issuer's initial public offering.
- F2The shares are held by Longitude Venture Partners II, L.P. ("Longitude Venture II"). Longitude Capital Partners II, LLC ("Longitude Capital II") is the general partner of Longitude Venture II and may be deemed to have sole voting, investment and dispositive power over the shares held by Longitude Venture II. Patrick G. Enright is a managing member of Longitude Capital II and in his capacity as such may be deemed to exercise shared voting and investment power over the shares held by Longitude Venture II. Mr. Enright disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F3Longitude Capital II purchased an additional 312,500 shares of Issuer's common stock in connection with the initial public offering at the offering price of $16.00 per share.
- F4The Series A Convertible Preferred Stock and Series B Preferred Convertible Stock have no expiration date.